Summary by Futu AI
Vipin K Garg, President and CEO of Altimmune, Inc. [ALT], completed a series of transactions involving the company's common stock between January 30, 2024, and January 31, 2024. On January 30, Garg exercised options to acquire 26,775 shares at no cost and subsequently disposed of 11,697 shares at a price of $9.80 per share to cover exercise prices or tax liabilities, leaving him with 264,333 shares. The following day, Garg acquired an additional 7,889 shares at $2.69 per share through a grant or award, bringing his total holdings to 272,222 shares after all transactions. The total value of the disposed shares amounted to $114,630.60.